沐舒坦雾化吸入联合静脉滴注治疗新生儿肺炎的临床疗效观察
|
摘要
目的观察沐舒坦雾化吸入联合静脉滴注治疗新生儿肺炎的临床疗效。方法选取我院2015年1月至2017年12月收治的160例新生儿肺炎患儿,随机分为两组各80例。对照组给予静脉滴注沐舒坦治疗,观察组给予雾化吸入联合静脉滴注沐舒坦治疗。比较两组的疗效、住院时间,以及气喘、咳嗽、肺部啰音消失时间。结果观察组的总有效率为96.25%,显著高于对照组的85.00%(P <0.05)。观察组的住院时间,以及气喘、咳嗽、肺部啰音消失时间均显著短于对照组(P <0.01)。结论沐舒坦雾化吸入联合静脉滴注治疗新生儿肺炎的疗效显著,可明显改善患儿的临床症状,提高治疗总有效率,缩短住院时间。
Objective To observe the clinical efficacy of mucosolvan aerosol inhalation combined with intravenous drip in the treatment of neonatal pneumonia. Methods 160 cases of neonatal pneumonia admitted to our hospital from January 2015 to December 2017 were selected and randomly divided into two groups, with 80 cases in each group. The control group was treated with mucosolvan by intravenous drip, while the observation group was treated with mucosolvan by intravenous drip and aerosol inhalation. The curative effect,hospitalization time, and the disappearance time of asthma, cough and pulmonary rales were compared between the two groups. Results The total effective rate of the observation group was 96.25%, significantly higher than 85.00% of the control group(P <0.05). The hospitalization time, and the disappearance time of asthma, cough and pulmonary rales of the observation group were significantly shorter than those of the control group(P <0.01). Conclusions Mucosolvan aerosol inhalation combined with intravenous drip has significant efficacy in the treatment of neonatal pneumonia, which can obviously improve the clinical symptoms of children, improve the total effective rate of treatment, and shorten hospitalization time.
Objective To observe the clinical efficacy of mucosolvan aerosol inhalation combined with intravenous drip in the treatment of neonatal pneumonia. Methods 160 cases of neonatal pneumonia admitted to our hospital from January 2015 to December 2017 were selected and randomly divided into two groups, with 80 cases in each group. The control group was treated with mucosolvan by intravenous drip, while the observation group was treated with mucosolvan by intravenous drip and aerosol inhalation. The curative effect,hospitalization time, and the disappearance time of asthma, cough and pulmonary rales were compared between the two groups. Results The total effective rate of the observation group was 96.25%, significantly higher than 85.00% of the control group(P <0.05). The hospitalization time, and the disappearance time of asthma, cough and pulmonary rales of the observation group were significantly shorter than those of the control group(P <0.01). Conclusions Mucosolvan aerosol inhalation combined with intravenous drip has significant efficacy in the treatment of neonatal pneumonia, which can obviously improve the clinical symptoms of children, improve the total effective rate of treatment, and shorten hospitalization time.
引文
[1]卢君,林广,林良武. 126例新生儿肺炎的临床分析[J].中国中西医结合儿科学, 2014, 6(3):256-258.
[2]姜万里.中西医结合治疗新生儿肺炎的疗效观察[J].中国中医药科技, 2016, 23(1):92-93.
[3]赵敏君,李凤云,李光荣.沐舒坦不同用药途径治疗新生儿肺炎的临床疗效及安全性分析[J].数理医药学杂志, 2015, 28(4):539-541.
[4]王正军.新生儿肺炎临床影像学检验特点分析[J].中国实用医药,2014, 9(22):69.
[5]倪晓辉.静脉滴注加雾化吸入沐舒坦治疗新生儿肺炎的疗效分析[J].医学信息, 2015, 28(18):255.
[6]付朝阳.沐舒坦雾化吸入联合静脉注射治疗新生儿肺炎的临床疗效观察[J].中国妇幼保健, 2015, 30(15):2442-2444.
[7]蔡霞.氨溴索减少早产低体重儿对氧气依赖的临床观察[J].中国伤残医学, 2016, 24(4):198-199.
[8]苏增玲,黄海波,温艳芬,等.沐舒坦雾化吸入结合静脉滴注治疗新生儿肺炎的临床效果[J].中国医药指南, 2014, 12(18):173-174.
[9]谢基灵.盐酸氨溴索支气管内给药的临床研究[J].中国实用医药,2013, 8(19):259-260.
[10]胡德飞,罗孝华,钟世冰.静脉滴注加雾化吸入沐舒坦治疗新生儿肺炎的疗效评价[J].基层医学论坛, 2016, 20(36):5087-5088.
[2]姜万里.中西医结合治疗新生儿肺炎的疗效观察[J].中国中医药科技, 2016, 23(1):92-93.
[3]赵敏君,李凤云,李光荣.沐舒坦不同用药途径治疗新生儿肺炎的临床疗效及安全性分析[J].数理医药学杂志, 2015, 28(4):539-541.
[4]王正军.新生儿肺炎临床影像学检验特点分析[J].中国实用医药,2014, 9(22):69.
[5]倪晓辉.静脉滴注加雾化吸入沐舒坦治疗新生儿肺炎的疗效分析[J].医学信息, 2015, 28(18):255.
[6]付朝阳.沐舒坦雾化吸入联合静脉注射治疗新生儿肺炎的临床疗效观察[J].中国妇幼保健, 2015, 30(15):2442-2444.
[7]蔡霞.氨溴索减少早产低体重儿对氧气依赖的临床观察[J].中国伤残医学, 2016, 24(4):198-199.
[8]苏增玲,黄海波,温艳芬,等.沐舒坦雾化吸入结合静脉滴注治疗新生儿肺炎的临床效果[J].中国医药指南, 2014, 12(18):173-174.
[9]谢基灵.盐酸氨溴索支气管内给药的临床研究[J].中国实用医药,2013, 8(19):259-260.
[10]胡德飞,罗孝华,钟世冰.静脉滴注加雾化吸入沐舒坦治疗新生儿肺炎的疗效评价[J].基层医学论坛, 2016, 20(36):5087-5088.